BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10653654)

  • 1. The amino-terminal nine amino acid sequence of poliovirus capsid VP4 protein is sufficient to confer N-myristoylation and targeting to detergent-insoluble membranes.
    Martín-Belmonte F; López-Guerrero JA; Carrasco L; Alonso MA
    Biochemistry; 2000 Feb; 39(5):1083-90. PubMed ID: 10653654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myristoylation is important at multiple stages in poliovirus assembly.
    Moscufo N; Simons J; Chow M
    J Virol; 1991 May; 65(5):2372-80. PubMed ID: 1850017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of myristoylation of poliovirus capsid protein VP4 as determined by site-directed mutagenesis of its N-terminal sequence.
    Marc D; Drugeon G; Haenni AL; Girard M; van der Werf S
    EMBO J; 1989 Sep; 8(9):2661-8. PubMed ID: 2555183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Capsid protein VP4 of poliovirus is N-myristoylated.
    Paul AV; Schultz A; Pincus SE; Oroszlan S; Wimmer E
    Proc Natl Acad Sci U S A; 1987 Nov; 84(22):7827-31. PubMed ID: 2825164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-terminal protein acylation confers localization to cholesterol, sphingolipid-enriched membranes but not to lipid rafts/caveolae.
    McCabe JB; Berthiaume LG
    Mol Biol Cell; 2001 Nov; 12(11):3601-17. PubMed ID: 11694592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Gly1 to Ala substitution in poliovirus capsid protein VP0 blocks its myristoylation and prevents viral assembly.
    Marc D; Girard M; van der Werf S
    J Gen Virol; 1991 May; 72 ( Pt 5)():1151-7. PubMed ID: 1851815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholesterol removal by methyl-beta-cyclodextrin inhibits poliovirus entry.
    Danthi P; Chow M
    J Virol; 2004 Jan; 78(1):33-41. PubMed ID: 14671085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myristoylation of EV71 VP4 is Essential for Infectivity and Interaction with Membrane Structure.
    Cao J; Qu M; Liu H; Wan X; Li F; Hou A; Zhou Y; Sun B; Cai L; Su W; Jiang C
    Virol Sin; 2020 Oct; 35(5):599-613. PubMed ID: 32399947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in the poliovirus P1 capsid precursor at arginine residues VP4-ARG34, VP3-ARG223, and VP1-ARG129 affect virus assembly and encapsidation of genomic RNA.
    Ansardi DC; Luo M; Morrow CD
    Virology; 1994 Feb; 199(1):20-34. PubMed ID: 8116243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myristate-protein interactions in poliovirus: interactions of VP4 threonine 28 contribute to the structural conformation of assembly intermediates and the stability of assembled virions.
    Moscufo N; Chow M
    J Virol; 1992 Dec; 66(12):6849-57. PubMed ID: 1331497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does lens intrinsic membrane protein MP19 contain a membrane-targeting signal?
    Chen T; Li X; Yang Y; Erdene AG; Church RL
    Mol Vis; 2003 Dec; 9():735-46. PubMed ID: 14735063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myristate modification does not function as a membrane association signal during poliovirus capsid assembly.
    Lee YM; Chow M
    Virology; 1992 Apr; 187(2):814-20. PubMed ID: 1312279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myristoylation of the poliovirus polyprotein is required for proteolytic processing of the capsid and for viral infectivity.
    Kräusslich HG; Hölscher C; Reuer Q; Harber J; Wimmer E
    J Virol; 1990 May; 64(5):2433-6. PubMed ID: 2157900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus type 16 minor capsid protein l2 N-terminal region containing a common neutralization epitope binds to the cell surface and enters the cytoplasm.
    Kawana Y; Kawana K; Yoshikawa H; Taketani Y; Yoshiike K; Kanda T
    J Virol; 2001 Mar; 75(5):2331-6. PubMed ID: 11160736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myristylation of picornavirus capsid protein VP4 and its structural significance.
    Chow M; Newman JF; Filman D; Hogle JM; Rowlands DJ; Brown F
    Nature; 1987 Jun 11-17; 327(6122):482-6. PubMed ID: 3035380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of a potential myristoylation site in hepatitis A virus capsid protein VP4.
    Tesar M; Jia XY; Summers DF; Ehrenfeld E
    Virology; 1993 Jun; 194(2):616-26. PubMed ID: 8389076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the myristoylation site in expressing exogenous functional proteins in coxsackieviral vector.
    Lim BK; Yun SH; Ju ES; Gil CO; Kim DK; Jeon ES
    Biosci Biotechnol Biochem; 2012; 76(6):1173-6. PubMed ID: 22790942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of myristoylation of poliovirus capsid polypeptide VP0 prevents the formation of virions or results in the assembly of noninfectious virus particles.
    Marc D; Masson G; Girard M; van der Werf S
    J Virol; 1990 Sep; 64(9):4099-107. PubMed ID: 2166807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distance-dependent cellular palmitoylation of de-novo-designed sequences and their translocation to plasma membrane subdomains.
    Navarro-Lérida I; Alvarez-Barrientos A; Gavilanes F; Rodriguez-Crespo I
    J Cell Sci; 2002 Aug; 115(Pt 15):3119-30. PubMed ID: 12118067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional roles for fatty acylated amino-terminal domains in subcellular localization.
    McCabe JB; Berthiaume LG
    Mol Biol Cell; 1999 Nov; 10(11):3771-86. PubMed ID: 10564270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.